Abdominal pain, a common clinical presentation, poses diagnostic challenges due to its myriad etiologies. This article aims to provide a comprehensive approach to evaluating abdominal pain.
Understanding the patient’s pain characteristics including onset, location, intensity, and associated symptoms is crucial. Inquiring about past medical history, medication use, and family history can provide valuable insights.
Physical examination should be systematic, starting with inspection and auscultation, followed by palpation and percussion. Signs of acute abdomen require immediate attention.
While non-specific, laboratory tests can support clinical suspicion. Full blood count, liver function tests, and amylase levels are commonly used.
Imaging modalities like ultrasonography, CT, and MRI can aid in visualizing the pathology. Choice of imaging depends on patient factors and suspected diagnosis.
Abdominal pain evaluation requires a systematic approach combining history, physical examination, and appropriate investigations. Continual learning and practice are key to mastering this complex task.
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation